Inhibrx Biosciences, Inc. (INBX)
(Delayed Data from NSDQ)
$20.94 USD
-0.87 (-3.97%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $20.91 -0.03 (-0.12%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Inhibrx Biosciences, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
INBX 20.94 -0.87(-3.97%)
Will INBX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for INBX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for INBX
Inhibrx Biosciences: Seeing Soon If The Momentum Is Just Hype
Noteworthy Tuesday Option Activity: INBX, ODP, AZO
Bullish Two Hundred Day Moving Average Cross - INBX
Inhibrx Biosciences Concludes 2025 Annual Stockholders Meeting
Analysts’ Opinions Are Mixed on These NA Stocks: Ibotta, Inc. Class A (IBTA) and Inhibrx Biosciences Inc (INBX)